<DOC>
	<DOCNO>NCT00518570</DOCNO>
	<brief_summary>The purpose study investigate clinical efficacy Levetiracetam treatment symptom premenstrual dysphoric disorder ( PMDD ) open label study .</brief_summary>
	<brief_title>Levetiracetam Treatment Patients With Premenstrual Dysphoric Disorder ( PMDD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Premenstrual Dysphoric Disorder</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>PMDD diagnostic severity criterion : 1 . Women PMDD accord DSMIVTR criterion At screen history At end Qualification Phase review symptom record . 2 . The first 2 consecutive 2 3 consecutive qualification cycle must fulfill follow criterion : For woman medication PMDD symptom : Late luteal phase ( 7 day include last six day menses day one ) daily average &gt; equal 3.5 least 4 7 day 5 distinct item overlap Daily Record Severity Problems ( DRSP ) Scale , least one item must represent nonphysical symptom . Entries diary must present least three day item used inclusion criterion month . Follicular phase ( day 812 first day menses ) daily average less equal 2.5 DRSP scale nonphysical symptom . The average calculated day 812 cycle , day 1 first day menstrual bleeding . Entries diary must present least three day item used inclusion criterion month . Late luteal phase ( 6 day menses day 1 ) daily average least twice high follicular phase daily average five distinct item . Functional impairment question late luteal phase require equal 4 score least one item least 2 day . For woman antidepressant oral contraceptive least 2 month : Late luteal phase daily average 2.5 least 4 7 day 5 distinct item overlap DRSPscale , least one item must represent nonphysical symptom . Entries diary must present least three day item used inclusion criterion month . Follicular phase daily average 2 less item DRSP scale nonphysical symptom . The average calculated day 812 cycle , day 1 first day menstrual bleeding . Entries diary must present least three day item used inclusion criterion month . Late luteal phase ( 6 day menses day 1 menses ) daily average least twice high follicular phase daily average three distinct item . Functional impairment question late luteal phase require 3 score least one item 2 day . 3 . Absence one follow Axis I disorder last 6 month : Major Depressive Disorder Anxiety Disorder ( Panic Disorder , OCD , PTSD ) Eating Disorder Drug alcohol abuse 4 . Absence follow Axis I disorder ( current history ) , base Mini International Neuropsychiatric interview ( MINI ) Bipolar Disorder Psychotic Disorder Somatoform Disorder Dysthymic Disorder Other criterion : 1 . Age 18 50 . 2 . Regular menstrual cycle 2month period precede enrollment Qualification Phase ( i.e . menstrual cycle length must 21 35 day ) 3 . Negative Pregnancy test prior Treatment Phase . 4 . Women must use effective form contraception ( oral contraceptive , Barrier method , intrauterine device , tubal ligation consider effective form contraception . ) 5 . Judged good physical health basis medical history , physical examination laboratory screening . 6 . Able understand procedure agree participate study sign informed consent ; investigator 's opinion , patient clearly intend comply requirement study . 1 . Women , pregnant , give birth within last 8 month , breastfeed intend become pregnant within 6 month . 2 . Contraindication hypersensitivity levetiracetam . 3 . Ongoing psychotherapy , begin &lt; 3months prior study visit . 4 . Participation another clinical trial within last 3 month prior screen visit . 5 . Known hypersensitivity Levetiracetam 6 . Any disease condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study medication . 7 . Severe systemic disease might interfere conduct study interpretation result . 8 . Uncontrolled thyroid problem . 9 . Active use substance , exclude caffeine nicotine , permit study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>PMDD</keyword>
	<keyword>PMS</keyword>
	<keyword>Levetiracetam</keyword>
</DOC>